In Depth 21 Dec 2020 Enemy or Valuable Ally? How Biotech Uses Viruses for Good Taking advantage of the ability of viruses to manipulate life is opening new doors for the biotech industry. Once only seen as our enemies, viruses are fast becoming some of… December 21, 2020 - 7 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Interview 4 Sep 2019 Overcoming Clinical Setbacks to Fight Insect-Borne Diseases Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas Lingelbach, shared his experience of migrating from big pharma to biotech, and how his first… September 4, 2019 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 Nov 2023 The biggest private biotech investments in October 2023 …month, with only a few major private funding rounds taking place within its biotech sector. In this article, we’ve gathered the necessary data on the biggest biotech investments that went… November 6, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2017 Swedish Biotech Faces Another Phase III Flop in Multiple Sclerosis Teva and Active Biotech have failed Phase III with their Multiple Sclerosis drug laquinimod to treat the relapsing-remitting form of the disease. Teva and Active Biotech have faced another setback… May 8, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Interview 18 Dec 2019 How BioNTech Navigates the Biotech Fundraising Maze …and Commercial Officer Sean Marett. It’s been an interesting year for the German biotech. In July the company raised one of the biggest ever European biotech fundraising rounds with its… December 18, 2019 - 6 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Infographics 21 Feb 2017 Infographic: The Biggest Biotech Company in Each European Country We had a look into European biotech and created a map with the biggest biotech companies in each country, according to their market cap. Biotech is one of the biggest… February 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jul 2022 FORTY51 Ventures closes $43M biotech fund and announces first investment FORTY51 Ventures has announced the closing of FORTY51 Ventures I, raising $43 million in its first close. FORTY51’s core strategy focuses on company formation and early-stage investments in biotech with… July 18, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 4 Sep 2023 The biggest private biotech investments in August 2023 …The fundraising companies have been split into healthcare and industrial biotechnology-focused verticals. Healthcare investments in August 2023 The U.S.’ top private biotech healthcare investments went to Genesis Therapeutics and ADARx… September 4, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Jul 2022 The biggest US biotech investments in June 2022 …biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round. In June 2022, the U.S. private biotech… July 5, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2018 New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech …biotech R&D. Qiagen and STAT-Dx’s plan is particularly exciting because their device hopes to make high-quality diagnostics more simple and accessible. With Qiagen paying a lot for the biotech, it… February 1, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 11 Sep 2023 Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary… September 11, 2023 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Privacy Policy This website https://www.labiotech.eu/ (“Website”) is operated by Labiotech UG (haftungsbeschränkt), represented by its Managing Director Caroline Edlund Toulemonde, Gotlandstr. 5, 10439 Berlin, Germany (“Labiotech” or “we”). For the processing of… May 3, 2018 - 21 minutesmins - By Developer Share WhatsApp Twitter Linkedin Email